Cardiomyopathies (dilated, hypertrophic, restrictive)
Cardiology · Cardiac
Physician-written · Verified by three sets of doctors · Reviewed November 2026
Bedside summary
Group the primary myocardial diseases by structure on echo — dilated (systolic failure), hypertrophic (diastolic, outflow obstruction, sudden death risk) and restrictive (impaired filling) — then treat the physiology and screen family. First action: transthoracic echo and a 12-lead ECG.
Red flags
- Refer all to cardiology/inherited cardiac conditions service
- Admit for decompensated failure, sustained arrhythmia, syncope or new high-risk features
- Urgent review for a young patient with exertional syncope and a murmur
Assessment
Investigations
- ECG (LVH, deep T-waves, Q-waves, conduction disease)
- Echo for chamber size, wall thickness, outflow gradient and diastolic function
- Cardiac MRI for tissue characterisation/fibrosis
- Genetic testing and family screening
- Amyloid work-up (serum free light chains, bone scintigraphy) if restrictive/HFpEF with red flags
Management
- DCM: standard heart-failure therapy (ACEi/ARNI, beta-blocker, MRA, SGLT2i) plus device therapy (ICD/CRT) by EF and QRS
- HCM: beta-blocker or verapamil for symptoms; avoid dehydration and pure vasodilators; septal reduction (myectomy/alcohol ablation) for refractory obstruction; mavacamten in selected obstructive HCM;
- ICD if high sudden-death risk
- Restrictive: treat the underlying cause and manage congestion cautiously
Disposition
Refer all to cardiology/inherited cardiac conditions service.
Complications & pitfalls
- Progressive heart failure, ventricular and atrial arrhythmias, sudden cardiac death (especially HCM), thromboembolism and, in restrictive/amyloid, rapid decompensation and conduction block
Exam pearls
- A systolic murmur that gets LOUDER on standing or Valsalva (less preload) points to dynamic HCM obstruction — the opposite of aortic stenosis — and should trigger echo and family screening.
- Monitoring & follow-up: Periodic echo and ECG/Holter; recalculate HCM sudden-death risk. First-degree relatives need clinical and genetic screening. Review device function and heart-failure therapy titration. Counsel on exercise restriction where indicated.
Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.